c‐Rel–dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesis
0301 basic medicine
Cancer Research
Carcinoma, Hepatocellular
Original Articles: Liver Cancer
Carcinogenesis
Physiology
Hepatocellular carcinoma
DNA repair
Apoptosis
Cancer research
Gene
Mice
Cell growth
03 medical and health sciences
Biochemistry, Genetics and Molecular Biology
Role of Nrf2 Signaling in Oxidative Stress Response
Genetics
Animals
Humans
Chemotherapy
Molecular Biology
Biology
Cancer
Programmed cell death
Mice, Knockout
Molecular Physiology of Purinergic Signalling
Liver Neoplasms
NF-kappa B
Life Sciences
DNA
Proto-Oncogene Proteins c-rel
3. Good health
Doxorubicin
FOS: Biological sciences
Hepatocytes
DNA damage
Nucleotide Signalling
NF-?B Signaling in Inflammation and Cancer
Transcription factor
DNA Damage
DOI:
10.1002/hep.32781
Publication Date:
2022-09-12T01:09:50Z
AUTHORS (18)
ABSTRACT
Background and Aims: Hepatocellular carcinoma (HCC) is a leading cause of cancer‐related death. The NF‐κB transcription factor family subunit c‐Rel typically protumorigenic; however, it has recently been reported as tumor suppressor. Here, we investigated the role in HCC. Approach Results: Histological transcriptional studies confirmed expression human patients with HCC, but low correlated increased cell proliferation mutational burden was associated advanced disease. In vivo , global ( Rel −/− ) epithelial specific Alb knockout mice develop more tumors, higher proliferative rate DNA damage, than wild‐type (WT) controls 30 weeks after N‐diethylnitrosamine injury. However, comparable when deleted hepatocytes once tumors were established, suggesting signaling important for preventing HCC initiation genotoxic injury, rather progression. vitro susceptible to injury WT controls. ATM‐CHK2 damage response pathway proteins suppressed following that required effective repair. To determine if inhibition sensitizes cancer cells chemotherapy, by repair chemotherapy‐induced thus increasing death, administered single or combination doxorubicin IT‐603 (c‐Rel inhibitor) therapy an orthotopic model. Indeed, efficacious alone. Conclusion: Hepatocyte limits subsequent burden. Inhibiting adjuvant effectiveness damaging agents reduced growth.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (46)
CITATIONS (8)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....